Overview

Vogelxo(R) ABPM Study in Hypogandal Men

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
A Phase 4 ABPM study in Hypogonadal Men
Phase:
Phase 4
Details
Lead Sponsor:
Upsher-Smith Laboratories
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate